Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

59.87
BATS BZX Real-Time Price
As of 1:40pm ET
 -1.75 / -2.84%
Today’s Change
50.71
Today|||52-Week Range
68.12
+1.06%
Year-to-Date
Trump warns Wall Street: I'm going to cut drug prices
10:40am / CNNMoney.com
Momenta Pharmaceuticals Announces Positive Results for Humira Biosimilar
Nov 30 / GuruFocus News - Paid Partner Content
Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data in Focus
9:32am / Zacks.com - Paid Partner Content
Momenta/Shire's Humira Biosimilar Meets Study Objective
Nov 30 / Zacks.com - Paid Partner Content
AbbVie, Johns Hopkins Unite for Cancer Research
Dec 06 / GuruFocus News - Paid Partner Content
Why the $324 Billion Bioeconomy Deserves a Place in Your Portfolio
Nov 30 / MotleyFool.com - Paid Partner Content
AbbVie (ABBV) Presents Impressive Imbruvica Data at ASH
Dec 06 / Zacks.com - Paid Partner Content
Big Pharma healthcare R&D steps out into the open
Nov 29 / FT.com - Paid Partner Content
Leukemia Treatment Achieves Promising Results
Dec 05 / GuruFocus News - Paid Partner Content
3 Top Drug Stocks for Your Retirement Portfolio
Nov 28 / MotleyFool.com - Paid Partner Content
Amgen/Allergan File for EU Approval of Avastin Biosimilar
Dec 05 / Zacks.com - Paid Partner Content
J&J confirms talks with Actelion over pharma deal
Nov 25 / FT.com - Paid Partner Content
FDA Orphan Drug Designation for AbbVie's Risankizumab
Dec 01 / GuruFocus News - Paid Partner Content
Galapagos (GLPG) Filgotinib in Phase III for Crohn's Disease
Nov 23 / Zacks.com - Paid Partner Content
AbbVie Crohn's Disease Drug Gets Orphan Drug Status in U.S.
Dec 01 / Zacks.com - Paid Partner Content
US stocks defy fears of panic with steady open after Trump win
Nov 09 / FT.com - Paid Partner Content